Compared side by side
Semax vs cerebrolysin: how they differ
The short answer
Both are used clinically after strokes, in very different forms: Semax is a seven-amino-acid nasal spray derived from ACTH, approved in Russia, and Cerebrolysin is a mixture of small peptides from porcine brain tissue, given by IM or IV injection, usually in a clinic. Cerebrolysin is approved in many countries outside the US, but its trial results are mixed, and an independent 2023 review found no effect on stroke deaths; Semax’s human data are small, mostly open-label Russian studies. Semax is taken daily in 2–4 week cycles, Cerebrolysin in 10–20 day courses.
Side by side
| Compared | Semax | Cerebrolysin |
|---|---|---|
| Category | Cognitive | Cognitive |
| Also known as | ACTH 4-7 Pro8Gly9Pro10, N-acetyl Semax | FPE 1070, Cerebrolysin injection |
| What it is | A nasal spray nootropic derived from ACTH but modified to remove hormonal effects. | A complex mixture of small peptides from porcine brain tissue, with reported growth-factor-like activity. |
| How it works | Synthetic heptapeptide derived from ACTH. In rats it raises BDNF and NGF expression, lifts serotonin turnover and amplifies stimulated dopamine release, which supports cognition, focus and neuroprotection. Used clinically in Russia for stroke recovery. | Neurotrophic peptide complex derived from porcine brain tissue: a digest of small peptides and amino acids with reported growth-factor-like activity (it doesn't contain intact BDNF, NGF or CNTF). Neuroprotective, and promotes neuroplasticity and neural repair, mostly in animal and cell studies. Used clinically for stroke and dementia in many countries particularly Eastern Europe and Asia. Typically administered in a clinical setting — self-administration carries additional risks. |
| Commonly reported | A quick lift in focus, alertness and mental energy within minutes to an hour, nasal stinging, and irritability or poor sleep at high doses or late in the day. Approved in Russia for stroke recovery and memory problems after brain injury. Often paired with Selank — Semax for drive, Selank for calm. | Clearer thinking, better word-finding or faster mental tempo during or after a course, injection discomfort from the large IM volumes, and dizziness, headache or a warm flush during injection. Given in 10-20 day courses, often repeated after a few months. |
| Studied range | Research range: 200–900 mcg. Studied in research — not a recommendation. | Research range: 5–10 ml. Studied in research — not a recommendation. |
| How often | Daily | Daily for 10–20 day cycles |
| Half-life | Very short (~minutes); CNS effects persist longer | Short (component peptides) |
| Route | Nasal spray | IM injection, IV infusion (clinical setting) |
| Typical run | 2–4 week cycles. Some use daily long-term without noted issues. Cycling still advised. | 10–20 day intensive courses, often repeated after a break of a few months, as in dementia trials. |
| Evidence | Moderate: animal studies + some human data | Established: clinical trials or FDA-approved use exists |
| Common side effects | Nasal irritation, headache, anxiety, increased energy (can disrupt sleep) | Injection site reactions, dizziness, warm sensation during IV infusion, headache |
- Category
- SemaxCognitive
- CerebrolysinCognitive
- Also known as
- SemaxACTH 4-7 Pro8Gly9Pro10, N-acetyl Semax
- CerebrolysinFPE 1070, Cerebrolysin injection
- What it is
- SemaxA nasal spray nootropic derived from ACTH but modified to remove hormonal effects.
- CerebrolysinA complex mixture of small peptides from porcine brain tissue, with reported growth-factor-like activity.
- How it works
- SemaxSynthetic heptapeptide derived from ACTH. In rats it raises BDNF and NGF expression, lifts serotonin turnover and amplifies stimulated dopamine release, which supports cognition, focus and neuroprotection. Used clinically in Russia for stroke recovery.
- CerebrolysinNeurotrophic peptide complex derived from porcine brain tissue: a digest of small peptides and amino acids with reported growth-factor-like activity (it doesn't contain intact BDNF, NGF or CNTF). Neuroprotective, and promotes neuroplasticity and neural repair, mostly in animal and cell studies. Used clinically for stroke and dementia in many countries particularly Eastern Europe and Asia. Typically administered in a clinical setting — self-administration carries additional risks.
- Commonly reported
- SemaxA quick lift in focus, alertness and mental energy within minutes to an hour, nasal stinging, and irritability or poor sleep at high doses or late in the day. Approved in Russia for stroke recovery and memory problems after brain injury. Often paired with Selank — Semax for drive, Selank for calm.
- CerebrolysinClearer thinking, better word-finding or faster mental tempo during or after a course, injection discomfort from the large IM volumes, and dizziness, headache or a warm flush during injection. Given in 10-20 day courses, often repeated after a few months.
- Studied range
- SemaxResearch range: 200–900 mcg. Studied in research — not a recommendation.
- CerebrolysinResearch range: 5–10 ml. Studied in research — not a recommendation.
- How often
- SemaxDaily
- CerebrolysinDaily for 10–20 day cycles
- Half-life
- SemaxVery short (~minutes); CNS effects persist longer
- CerebrolysinShort (component peptides)
- Route
- SemaxNasal spray
- CerebrolysinIM injection, IV infusion (clinical setting)
- Typical run
- Semax2–4 week cycles. Some use daily long-term without noted issues. Cycling still advised.
- Cerebrolysin10–20 day intensive courses, often repeated after a break of a few months, as in dementia trials.
- Evidence
- SemaxModerate: animal studies + some human data
- CerebrolysinEstablished: clinical trials or FDA-approved use exists
- Common side effects
- SemaxNasal irritation, headache, anxiety, increased energy (can disrupt sleep)
- CerebrolysinInjection site reactions, dizziness, warm sensation during IV infusion, headache
Typical run: Community practice — opinions vary. Not a clinical recommendation.

Week by week
Each entry’s cards by day window, as the compound pages show them. Day 1 is the day you start it.
Semax
- Day 1–3 Focus snaps into place
- Day 3–7 Each dose builds on the last
- Day 7–14 Learning speed is up
- Day 14–28 The end of a typical cycle
Cerebrolysin
- Day 1–5 Intensive course mode
- Day 5–20 Mid-course cognitive lift
- Day 20–90 Post-course consolidation
Together or one or the other
Semax and cerebrolysin are a common stack: cerebrolysin lists semax among its common stacks.
Questions people ask
How long do semax and cerebrolysin last?
The half-life of semax is very short (~minutes); CNS effects persist longer. The half-life of cerebrolysin is short (component peptides).
How often are semax and cerebrolysin taken?
Semax: daily. Route: Nasal spray. Cerebrolysin: daily for 10–20 day cycles. Routes: IM injection, IV infusion (clinical setting).
How are semax and cerebrolysin dosed in research?
The research range for semax is 200–900 mcg. The research range for cerebrolysin is 5–10 ml. Studied in research — not a recommendation.
What are the common side effects of semax and cerebrolysin?
For semax, the library lists: nasal irritation, headache, anxiety, increased energy (can disrupt sleep). For cerebrolysin: injection site reactions, dizziness, warm sensation during IV infusion, headache.
Are semax and cerebrolysin taken together?
Semax and cerebrolysin are a common stack: cerebrolysin lists semax among its common stacks.